Skip to main content

A Phase 2 Study to Evaluate the Safety, Tolerability, and Clinical Activity of BLU-808, a Wild Type KIT Inhibitor, in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria

Open
  • Protocol code: BLU-808-1201
  • EudraCT code: No aplica
  • Research group: Systemic Diseases
  • Service: Internal Medicine
  • Principal investigator:  Labrador Horrillo, Moisés
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II